Moderna’s COVID-19 vaccine has received full FDA approval for use in children at higher risk for severe illness.

Shares of biotechnology company Moderna (NASDAQ:MRNA) fell 3.6% in the morning session after JPMorgan added the stock to its ...

The company expects to make the updated Spikevax available to U.S. patients in time for the 2025-26 respiratory virus season.

Moderna is expected to announce its second-quarter results in the upcoming month, and analysts expect a slight reduction in ...

The average short interest for the S&P 500 Health Care Index Sector (NYSEARCA:XLV) experienced an increase in June, moving ...

The mRNA technology behind the Pfizer and Moderna vaccines are groundbreaking, but their potential goes way beyond COVID-19.

This is what it looks like when disinformation doctors pretend to value data and science to further their true objective, ...

Today in History: On July 14, 1789, in an event symbolizing the start of the French Revolution, citizens of Paris stormed the ...

Welcome to Fierce Pharma's regulatory tracker for the second half of 2025. | In this tracker, Fierce Pharma is recording the ...

Screening of more than 12,000 Aspergillus fumigatus isolates collected from Dutch hospitals found 15% harbored triazole ...

Pennsylvania first detected CWD in 2012 in Adams County, and the disease has since spread to all south-central counties, ...